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BACKGROUND: This study investigated the risk of cancer in children with alert symptoms identified in current UK guidance, or with
increased consultation frequency in primary care.
METHODS: A population-based, nested case–control study used data from the General Practice Research Database. In all, 1267
children age 0–14 years diagnosed with childhood cancer were matched to 15 318 controls. Likelihood ratios and positive predictive
values (PPVs) were calculated to assess risk.
RESULTS: Alert symptoms recorded in the 12 and 3 months before diagnosis were present in 33.7% and 27.0% of cases vs 5.4% and
1.4% of controls, respectively. The PPV of having cancer for any alert symptom in the 3 months before diagnosis was 0.55 per 1000
children. Cases consulted more frequently particularly in the 3 months before diagnosis (86% cases vs 41% controls). Of these, 36%
of cases and 9% of controls had consulted 4 times or more. The PPV for cancer in a child consulting 4 times or more in 3 months was
0.13 per 1000 children.
CONCLUSION: Alert symptoms and frequent consultations are associated with childhood cancer. However, individual symptoms and
consultation patterns have very low PPVs for cancer in primary care (e.g., of 10 000 children with a recorded alert symptom,
approximately 6 would be diagnosed with cancer within 3 months).
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Cancer in children is rare, with an annual incidence among 0- to
14-year olds in the United Kingdom of just under 1.4 per 10 000
(Cancer Research UK, 2010) and provides a major diagnostic
challenge to all clinicians, particularly those in primary care.
Delayed diagnosis may worsen survival; at the very least it reduces
the confidence of patients and parents in their doctor (Dixon-
Woods et al, 2001; Craft and Pritchard-Jones, 2007; Larsen et al,
2011). Improving early diagnosis is a priority in the UK Cancer
Reform Strategy (Department of Health, 2007, 2011) and other
parts of Europe (Olesen et al, 2009). As most patients see their GP
before diagnosis, the focus of research should be in primary care.
The UK National Institute for Health and Clinical Excellence
(NICE) is an independent organisation responsible for providing
national guidance on promoting good health and preventing and
treating ill health. They have produced guidelines, which describe
symptoms that should alert GPs to consider cancer seriously
(National Institute for Health and Clinical Excellence, 2005),
including cancer in children. These were first published in 2000,
and updated in 2005. Lists of alert symptoms are provided for each
childhood cancer and some are stratified by age; for example,
unexplained hepatosplenomegaly at any age is listed as indicating
immediate referral for investigation of leukaemia or lymphoma.
However, they were developed in the absence of any supporting
primary care research in children, and thus largely describe
symptoms deemed pathognomic of cancer at the time of diagnosis
in tertiary care. How relevant such symptoms are to children in
primary care (and earlier in their diagnostic pathway) is unknown.
The aim of this study was to investigate the risk of cancer in
children with alert symptoms and increased consultation frequency
as described in current NICE guidance.
MATERIALS AND METHODS
Study design
We undertook a population-based case–control study nested
within a cohort of children registered with the UK General Practice
Research Database (GPRD) (www.gprd.com). The GPRD is a
prospectively gathered, anonymised database that holds long-
itudinal administrative, clinical and prescribing records (including
all consultations and diagnoses) of 11 million patients, from over
600 general practices across the United Kingdom (covering
approximately 8% of the population) (General Practice Research
Database, 2011). Individuals registered on the database are
representative of the UK population in terms of age, sex and
geographical distribution (Office for National Statistics, 2000a).
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Data are subject to thorough validation (Herrett et al, 2010; Khan
et al, 2010), audit and quality checks, and have been used in4800
peer reviewed publications, including studies to identify and
quantify the symptoms of colorectal (Lawrenson et al, 2006;
Hamilton et al, 2008, 2009) and brain tumours (Hamilton and
Kernick, 2007), and alarm symptoms in adult cancers (Jones et al,
2007).
Study population
The sample comprised all children aged 0–14 years, inclusive,
drawn from all general practices contributing research-standard
data to the GPRD between 1 January 1988 and 31 December 2010.
To be included, the practices had to have been contributing
research-standard data for a minimum of 1 year before each child’s
date of cancer diagnosis or the index date (see below) for matched
controls.
Cases and controls
The cases were diagnosed with the following cancers: leukaemia,
lymphoma, neuroblastoma, soft tissue sarcoma, hepatic, renal,
bone and central nervous system tumours, using pre-defined
medical codes used in the GPRD (available from investigators).
The date of diagnosis for cases was defined as the date of
pathological diagnosis, but if this was unavailable, we used the date
of the first cancer code entered in the GPRD. Up to 13 controls
(children with no diagnosis of cancer at any time) were selected
per case, using a computer-generated random sequence, matched
on age (within 1 year), sex and practice, and had to be currently
registered on the date of diagnosis of their matched case (the index
date). Matching was performed on age and sex, as these are
strongly associated with consultation rates, and practice, because
each practice has its own protocols and/or conventions for record
keeping.
The GPRD restricts its data sets to 100 000 individuals for
projects funded through the Medical Research Council licence
agreement. This restriction mandated a case–control rather than
cohort design to ensure we identified sufficient cases of cancer for
each particular symptom to provide sufficient power to detect
associations (see power calculations below).
Symptoms and consultations
The GPRD uses just over 100 000 medical codes to encompass all
primary care events, including both symptoms and diagnoses.
From this list, we assembled libraries of codes representing
individual alert symptoms derived from the NICE referral guide-
lines for suspected cancer in children: these were compiled
separately by RMD and WH, and differences agreed by consensus.
Two conditions that we considered to be unrelated to cancer were
included (head lice, acne) to identify and quantify any recording
bias (whereby patients with cancer attend more frequently, so have
more opportunities for a symptom to be recorded). In the absence
of recording bias, we would anticipate no association of the
recording of head lice or acne with subsequent diagnosis of cancer.
In contrast, in the presence of better recording among cancer
cases, we might have seen a general increase in recording for all
symptoms, irrespective of whether they could be plausibly related
to the cancer.
Consultations in the 12 months before diagnosis were identified,
a priori, over three time periods before the index date: 0–3
months, 4–6 months and 7–12 months.
Analysis
Participants were stratified by age-group (0–4 years and 5–14
years). The magnitude of associations of alert symptoms and
patterns of consultation frequency with cancer were identified
using univariable conditional logistic regression. To assess the
value of symptoms and consultation patterns in diagnosing cancer,
likelihood ratios (LRs) and positive predictive values were
calculated (Hamilton, 2010). We calculated the PPV using Bayes’
theorem, whereby posterior odds¼ prior odds LR (Knottnerus,
2002). We estimated the prior odds from national incidence figures
for 2008 (ISD Online, 2009; Northern Ireland Cancer Registry,
2009; Office for National Statistics, 2009; Welsh Cancer Intelligence
and Surveillance Unit, 2009), expressed as the odds of developing
cancer in 1 year. Annual incidence figures were divided by 4 for the
analyses of 3-month time periods. All analyses were performed
using Stata, version 10 (Stata Corporation, College Station, TX,
USA, 2008).
Power calculation
Sample sizes were predetermined by the cancer numbers in the
GPRD, so we performed a power calculation, with two-sided 5%
significance. An estimated 350 cases (e.g., of leukaemia) and 13
controls per case provided over 99% power to identify a change in
the prevalence of a rare variable from 5% in controls to 10% in
cases. For rarer cancers, an estimated 80 cases (e.g., of
neuroblastoma) and 13 controls per case provided over 84%
power to identify a change in a rare variable from 5% in controls to
15% in cases and 97% power to identify a change in a common
variable from 30 to 50%.
RESULTS
In all, 1267 eligible cases of childhood cancer and a corresponding
15 318 eligible controls were identified. Their diagnoses, age-
groups and gender are summarised in Table 1. In line with UK
demography (Office for National Statistics, 2000b), 34% of cases
were aged 0–4 compared with 31% of controls; 55% of cases and
controls were male; and 83% of cases and controls were from
England.
Table 2 shows the overall frequency of recorded alert symptoms
for the total study, along with odds ratios (ORs), LRs and PPVs. In
all, 27.0% of cases had a recorded alert symptom in the 3 months
before diagnosis compared with 1.4% of controls (OR: 28.8; 95%
CI: 23.5, 35.3). In the year before diagnosis, 33.7% of cases had any
alert symptom recorded compared with 5.4% of controls (OR: 9.8;
95% CI: 8.5, 11.4). Thus, having an alert symptom is associated
with an increased odds of cancer of up to 28.8-fold compared with
consulting without an alert symptom. The LRs were 19.6 and 6.2
for symptoms in the 3 months or 12 months before diagnosis,
respectively, suggesting that alert symptoms should alter the prior
probabilities somewhat. However, the PPV of having cancer in a
patient consulting with any alert symptom in the 0- to 3-month
period was 0.55 per 1000 children and in the 12-month period was
0.70 per 1000 children. Thus, of 10 000 children with a recorded
alert symptom, only up to 6 would be diagnosed with cancer within
3 months. This low PPV is because the prior probability of cancer
in this age-group is very small (approximately 1.4 in 10 000 per
annum and 0.35 in 10 000 in a 3-month period (Cancer Research
UK, 2010). Results were similar when stratified by age-group.
Table 3 shows the frequencies, magnitudes of associations (ORs)
and diagnostic performance (LRs and PPVs) of specific symptoms.
Neurological symptoms, excluding headache, were most frequently
recorded in all cases, followed by headache and lymphadenopathy.
Headache was more common in the older age-group and lymph-
adenopathy in the younger age-group. Although the LRs range
from 4.9 to 169.3, the PPVs are low. Hepatosplenomegaly had the
highest PPV: of 10 000 children with a record of hepatosplenome-
galy, our estimates suggest that 219 would have cancer. The OR
and LR for the control conditions (acne and head lice) were 1.0.
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Table 4 shows consultation rates. Cases consulted more than
controls in the year before diagnosis. This was consistent across all
diagnostic groups. Differences in consultation rates between cases
and controls were most apparent in the 3 months immediately
before diagnosis with cases having a median of three consultations
(interquartile range (IQR) 2–4) compared with one consultation
(IQR 1–2) in controls.
Among cases, 86.0% had seen their GP in the 3 months before
cancer diagnosis compared with 40.9% of controls (OR: 10.1; 95%
CI: 8.5, 11.9). Of these, 35.5% of cases had consulted 4 times or
more compared with 9.1% of the controls (OR: 12.4; 95% CI: 10.0,
15.3). Thus, consulting 4 times or more in 3 months is associated
with an increased odds of cancer of up to 12.4-fold compared with
consulting just once. However, the PPV for childhood cancer in a
patient consulting 4 times or more in 3 months was only 0.01%.
Thus, of 10 000 children consulting 4 times or more in 3 months,
only 1 would be diagnosed with cancer (compared with a prior
probability of cancer of 0.35 in 10 000 in a 3-month period)
(Cancer Research UK, 2010).
DISCUSSION
This study confirms an association between alert symptoms and
childhood cancer. Every symptom in NICE guidance was more
commonly recorded in cases than controls. However, individual
symptoms were relatively uncommonly recorded in cases: overall
just over a quarter of cases had any alert symptom recorded in the
3 months, and only a third had one in the year, before diagnosis.
Alert symptoms were also recorded in controls: this, coupled
with the rarity of childhood cancer, meant that any individual
symptom had a very low PPV for cancer in primary care. Only
hepatosplenomegaly had a PPV above 10 per 1000 children, but
even this was based on only 14 cases. Children with cancer see
their doctors more frequently, particularly in the 3 months before
diagnosis. Even so, the absolute risk of cancer in a patient
consulting four or more times is only 0.13 per 1000.
Strengths and weaknesses
This is the first study of childhood cancer to use primary care data
that has been collected prospectively. It is large, and practices in
the GPRD are broadly representative of the UK population
(General Practice Research Database, 2011), so our results should
be generalisable. The breakdown of cancers generally matched
nationally reported figures, with leukaemia the most common
diagnosis overall and CNS tumours the most common solid
tumour. Our cohort had a larger than expected number of bone
tumours, which was most apparent, as expected, in the 5- to
14-year age-group (Stiller et al, 2007). In comparison with national
age-specific statistics for 2010 (Cancer Research UK, 2010), there
appeared to be an under-ascertainment of some cancers in the 0–4
age-group, by approximately 10% for leukaemia, lymphoma, brain,
soft tissue sarcoma and neuroblastoma. Such under-ascertainment
could influence the magnitude of the associations we observed for
consultation frequency and alert symptoms with cancer, if these
variables were related to the likelihood of cancer being recorded in
the GPRD. This could occur, for example, if those children without
an alert symptom or fewer consultations were less likely to have
their final cancer diagnosis recorded in the GPRD than those
with an alert symptom. However, if this were the case, we would
have overestimated the PPVs for alert symptoms and hence this
potential limitation does not detract from our main finding that
individual symptoms and consultation patterns have low PPVs for
cancer in primary care.
The data were collected prospectively, precluding recall bias.
Recording bias is a theoretical possibility (e.g., when features of
cancer are preferentially recorded in patients who turn out to haveT
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Table 2 The association of having any NICE alert symptom and a diagnosis of cancer, all cases
Cases (N¼ 1267) Control (N¼ 15 318)
Age-group, period
before diagnosis Freq. % Freq. % OR (95% CI) Sensitivity Specificity
Likelihood
ratio
Positive predictive value
(per 1000) (95% CI)
All ages
0–3 Months 342 26.99 211 1.38 28.8 (23.5–35.3) 27.0 98.6 19.60 0.55 (0.47–0.65)
0–12 Months 427 33.70 829 5.41 9.8 (8.5–11.4) 33.7 94.6 6.23 0.70 (0.64–0.78)
0–4 Year age-group
N 436 4802
0–3 Months 96 22.02 55 1.15 25.2 (17.3–36.7) 22.0 98.9 19.22 0.81 (0.59–1.12)
0–12 Months 124 28.44 248 5.16 8.1 (6.2–10.5) 28.4 94.8 5.51 0.93 (0.77–1.13)
5–14 Year age-group
N 831 10 516
0–3 Months 246 29.60 156 1.48 30.4 (23.8–38.7) 29.6 98.5 19.96 0.56 (0.47–0.68)
0–12 Months 303 36.46 581 5.52 10.7 (9.0–12.8) 36.5 94.5 6.60 0.75 (0.66–0.84)
Abbreviations: CI¼ confidence interval; NICE¼ National Institute for Health and Clinical Excellence; OR¼ odds ratio. All case–control comparisons were strongly significant
with P-values o0.001.
Table 3 The association of selected alert symptoms and a diagnosis of cancer, all cases, 0–12 months
Cases Control
Symptom Freq. % Freq. % OR (95% CI)a
Likelihood
ratio
Positive predictive value
(per 1000) (95% CI)
All cases
N 1267 15 318
Alert symptoms
Neurological symptoms 108 8.52 207 1.35 7.0 (5.5–8.9) 6.31 0.83 (0.67–1.05)
Headache 90 7.10 224 1.46 5.6 (4.3–7.3) 4.86 0.64 (0.51–0.82)
Lymphadenopathy 82 6.47 136 0.89 8.2 (6.2–11.0) 7.29 0.96 (0.74–1.26)
Lump/mass/swelling 56 4.42 52 0.34 14.2 (9.5–21.1) 13.02 1.72 (1.19–2.50)
Fatigue 47 3.71 88 0.57 6.8 (4.7–9.8) 6.46 0.85 (0.60–1.21)
Back pain 40 3.16 73 0.48 7.6 (5.1–11.3) 6.62 0.88 (0.60–1.28)
Bruising 38 3.00 76 0.50 6.0 (4.1–9.0) 6.04 0.80 (0.54–1.18)
Urinary symptoms 15 1.18 9 0.06 21.0 (9.2–47.9) 20.15 2.66 (1.17–6.09)
Hepatosplenomegaly 14 1.10 1 0.01 149.6 (19.6–1142.6) 169.26 21.9 (2.95–170.34)
Control conditions (acne, head lice) 23 1.82 278 1.81 1.0 (0.7–1.6) 1.00 0.13 (0.09–0.20)
0–4 Year age-group
N 436 4802
Alert symptoms
Neurological symptoms 43 9.86 105 2.19 5.3 (3.6–7.7) 4.51 0.76 (0.54–1.07)
Headache 8 1.83 11 0.23 8.9 (3.6–22.2) 8.01 1.35 (0.55–3.35)
Lymphadenopathy 20 4.59 61 1.27 4.1 (2.4–7.0) 3.61 0.61 (0.37–1.00)
Lump/mass/swelling 16 3.67 15 0.31 11.6 (5.6–24.1) 11.75 1.98 (0.99–3.99)
Fatigue 15 3.44 32 0.67 5.8 (3.0–11.0) 5.16 0.87 (0.48–1.60)
Back pain 4 0.92 4 0.08 12.9 (3.2–51.5) 11.01 1.86 (0.47–7.42)
Bruising 20 4.59 24 0.50 9.3 (5.0–17.3) 9.18 1.55 (0.86–2.79)
Urinary symptoms 8 1.83 2 0.04 49.2 (10.4–231.6) 44.06 7.39 (1.59–34.96)
Hepatosplenomegaly 7 1.61 1 0.02 67.1 (8.1–554.4) 77.10 12.86 (1.61–105.69)
Control conditions (acne, head lice) 8 1.83 50 1.04 2.0 (0.9–4.3) 1.76 0.30 (0.14–0.62)
5–14 Year age-group
N 831 10 516
Alert symptoms
Neurological symptoms 65 7.82 102 0.97 8.6 (6.3–11.9) 8.06 0.91 (0.67–1.23)
Headache 82 9.87 213 2.03 5.4 (4.1–7.1) 4.87 0.55 (0.43–0.70)
Lymphadenopathy 62 7.46 75 0.71 11.7 (8.2–16.6) 10.46 1.18 (0.85–1.64)
Lump/mass/swelling 40 4.81 37 0.35 15.4 (9.6–24.7) 13.68 1.54 (0.99–2.40)
Fatigue 32 3.85 56 0.53 7.4 (4.8–11.5) 7.23 0.82 (0.53–1.25)
Back pain 36 4.33 69 0.66 7.2 (4.7–11.0) 6.60 0.75 (0.50–1.11)
Bruising 18 2.17 52 0.49 4.5 (2.6–7.6) 4.38 0.49 (0.29–0.84)
Urinary symptoms 7 0.84 7 0.07 12.8 (4.5–36.4) 12.65 1.43 (0.50–4.07)
Hepatosplenomegaly 7 0.84 0 0.00
Control (acne, head lice) 15 1.81 228 2.17 0.8 (0.5–1.4) 0.83 0.09 (0.06–0.16)
Abbreviations: CI¼ confidence interval; OR¼ odds ratio. aCompared with those without symptoms; computed using conditional logistic regression. All alert symptom case–
control comparisons were strongly significant with P-valueso0.001. Neurological symptoms – seizures, reduced conscious level, cranial nerve abnormalities, visual disturbances,
gait abnormalities, motor or sensory signs, unexplained deteriorating school performance or developmental milestones, unexplained behavioural and/or mood disturbance.
Urinary symptoms – retention, haematuria.
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cancer), but it is more likely that symptoms are under-recorded in
the GPRD (doctors preferring to record diagnoses where possible).
Under-recording should not affect LRs (which underpin PPVs) as
long as it is consistent between cases and controls; we have no
reason to think this is not the case. The OR and LR of 1 for the
control conditions (head lice or acne) suggests no recording bias in
relation to patients with cancer attending more frequently, so
having more opportunities for a symptom to be recorded.
We derived alert symptoms from the NICE referral guidance for
childhood cancer (National Institute for Health and Clinical
Excellence, 2005). However, because of the limitations of electronic
coding it is difficult to capture the nuances of both the clinical
consultation and the NICE guidance regarding symptom intensity
and progression. Instinct has a part in all diagnosis, with cancer
being no exception (Stolper et al, 2009) (especially rare cancers,
as GPs do not encounter enough cases to become experienced):
this will not have been captured by this study.
Comparison with previous literature
The low incidence of alert symptoms in the control population is
consistent with findings in teenagers and young adults suggesting
such symptoms are reported in only 4% of consultations (Fern et al,
2011). Increased primary care consultation rates have been reported
in children diagnosed with brain tumours up to 6 months before
diagnosis (Ansell et al, 2010). Our data are also consistent with the
observation that parents will continue to return to their GP because
their instinct is that their child ‘is not right’ although they may be
unable to identify a specific problem (Dixon-Woods et al, 2001).
Implication of the findings
Having any alert symptom does alter the prior probability of
cancer in the subsequent 3 months, from the underlying rate of
around 0.35 in 10 000 in 3 months among 0- to 14-year olds
(Cancer Research UK, 2010) to 6 in 10 000. Our data suggest,
however, that the current NICE guidelines have a limited role in
primary care, as their predictive value for childhood cancer is so
low. The problem is not with the symptom list or the fact that it
was derived from tertiary care data – as all symptoms were
associated with cancer – but with how a GP is supposed to select
children for investigation by a paediatrician. It is unrealistic to
suggest that all patients with alert symptoms should be referred.
Instead, GPs will have to use additional clues, such as an increased
consultation frequency (with four consultations in 3 months
appearing a reasonable starting point), abnormal examination
findings, multiple symptoms and their instinct. We could not
study parental concern, although this is potentially relevant too.
One advantage of primary care is the ease of review: ‘safety-
netting’ is increasingly recognised as important in adult cancer
diagnosis – and may be even more pertinent with children
(Almond et al, 2009). This may be particularly relevant if patients
consult different GPs with what appear to be independent illnesses
or complaints. Our findings support the NICE recommendation of
urgent referral for a child presenting several times with the same
problem, but no clear diagnosis (National Institute for Health and
Clinical Excellence, 2005).
Conclusion
Alert symptoms and frequent consultations are associated with
childhood cancer. However, individual symptoms and consultation
patterns have very low PPVs for cancer in primary care.
Future studies, including qualitative ones, may help to define the
symptoms of cancer in children further. Although these would
necessarily be retrospective, they could include the parents and
clinicians. This may allow better precision of what symptoms
actually matter. Until then, we have a fairly blunt instrument of
Table 4 The association between the number of consultationsa and a diagnosis of cancer, 0–3 months before diagnosis
Case Control
Number of
consultations Freq. %b Freq. %b ORc (95% CI)
Likelihood
ratio
Positive predictive value
(per 1000) (95% CI)
All cases
N 1267 15 318
No consultations 178 14.0 9056 59.1 1.0
With consultations 1089 86.0 6262 40.9 10.1 (8.5–11.9) 2.1 0.07 (0.07–0.07)
1 262 24.1 3565 56.9 1.0
2 252 23.1 1457 23.3 2.7 (2.2–3.3) 1.0 0.03 (0.03–0.04)
3 188 17.3 668 10.7 4.9 (3.9–6.1) 1.6 0.05 (0.05–0.06)
4 or more 387 35.5 572 9.1 12.4 (10.0–15.3) 3.9 0.13 (0.12–0.14)
0–4 Year age-group
N 436 4802
No consultations 50 11.5 2093 43.6 1.0
With consultations 386 88.5 2709 56.4 6.1 (4.5–8.4) 1.6 0.07 (0.06–0.07)
1 82 21.2 1370 50.6 1.0
2 83 21.5 669 24.7 2.4 (1.7–3.3) 0.9 0.04 (0.03–0.05)
3 68 17.6 335 12.4 4.2 (3.0–6.1) 1.4 0.06 (0.05–0.08)
4 or more 153 39.6 335 12.4 9.8 (7.0–13.7) 3.2 0.14 (0.12–0.16)
5–14 Year age-group
N 831 10 516
No consultations 128 15.4 6963 66.2 1.0
With consultations 703 84.6 3553 33.8 11.9 (9.8–14.5) 2.5 0.07 (0.07–0.07)
1 180 25.6 2195 61.8 1.0
2 169 24.0 788 22.2 2.8 (2.2–3.6) 1.1 0.03 (0.03–0.04)
3 120 17.1 333 9.4 5.2 (3.9–7.0) 1.8 0.05 (0.04–0.06)
4 or more 234 33.3 237 6.7 14.3 (10.9–18.9) 5.0 0.14 (0.12–0.17)
Abbreviations: CI¼ confidence interval; GP¼ general practice; OR¼ odds ratio. aAll primary care consultations including out of hours and telephone consultations.
bFor categories 1, 2, 3 and 4 or more, proportions reflect only patients with consultations. cOR: represents the odds of being diagnosed with cancer given more consultations
with the GP; computed using conditional logistic regression.
Features of childhood cancer in primary care
RM Dommett et al
986
British Journal of Cancer (2012) 106(5), 982 – 987 & 2012 Cancer Research UK
E
p
id
e
m
io
lo
g
y
NICE guidance to help with selection of children for investigation.
What is clear is that the current position is unsatisfactory: delays
(or perceived delays) in diagnosis can have major implications
on acceptance of a cancer diagnosis and a patient and family’s
subsequent healthcare-seeking behaviour.
ACKNOWLEDGEMENTS
RMD is funded by the National Institute for Health Research
(NIHR). WH was part funded by a NIHR postdoctoral fellowship.
This study is based on data from the Full Feature General Practice
Research Database (GPRD) obtained under licence from the UK
Medicines and Healthcare Products Regulatory Agency (MHRA).
However, the interpretation and conclusions contained in this study
are those of the author/s alone. Access to the GPRD was funded
through the Medical Research Council (MRC) licence agreement
with the UK Medicines and Healthcare Products Regulatory Agency.
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
The conduct of this study was approved by the Independent
Scientific Advisory Committee (ISAC) of the MHRA (Protocol
10_056) and the University of Bristol (reference: 35515).
REFERENCES
Almond S, Mant D, Thompson M (2009) Diagnostic safety-netting. Br J Gen
Pract 59(568): 872–874; discussion 874
Ansell P, Johnston T, Simpson J, Crouch S, Roman E, Picton S (2010) Brain
tumor signs and symptoms: analysis of primary health care records from
the UKCCS. Pediatrics 125(1): 112–119
Cancer Research UK (2010) Childhood Cancer- Great Britain and the UK.
http://info.cancerresearchuk.org/cancerstats/childhoodcancer (accessed on
18 September 2011)
Craft AW, Pritchard-Jones K (2007) UK childhood cancer survival falling
behind rest of EU? Lancet Oncol 8: 662–663
Department of Health (2007) Cancer Reform Strategy: Achieving Local
Implementation- Second Annual Report. London
Department of Health (2011) Improving Outcomes: A Strategy for Cancer.
http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/docu-
ments/digitalasset/dh_123394.pdf (accessed on 20 September 2011)
Dixon-Woods M, Findlay M, Young B, Cox H, Heney D (2001) Parents’
accounts of obtaining a diagnosis of childhood cancer. Lancet 357(9257):
670–674
Fern LA, Campbell C, Eden TO, Grant R, Lewis I, Macleod U, Weller D,
Whelan J (2011) How frequently do young people with potential cancer
symptoms present in primary care? Br J Gen Pract 61(586): e223–e230
General Practice Research Database (2011) http://www.gprd.com/gprd/
factsandfigures.asp (accessed on 18 September 2011)
Hamilton W (2010) Cancer diagnosis in primary care. Br J Gen Pract
60(571): 121–128
Hamilton W, Kernick D (2007) Clinical features of primary brain tumours:
a case-control study using electronic primary care records. Br J Gen Pract
57(542): 695–699
Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K, Marshall T (2009)
The risk of colorectal cancer with symptoms at different ages and
between the sexes: a case-control study. BMC Med 7: 17
Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T (2008)
The importance of anaemia in diagnosing colorectal cancer: a case-control
study using electronic primary care records. Br J Cancer 98(2): 323–327
Hamilton W, Peters TJ, Round A, Sharp D (2005) What are the clinical
features of lung cancer before the diagnosis is made? A population based
case-control study. Thorax 60(12): 1059–1065
Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ (2010) Validation
and validity of diagnoses in the General Practice Research Database:
a systematic review. Br J Clin Pharmacol 69: 4–14
ISD Online (2009) Information and Statistics Division, NHS Scotland.
http://www.isdscotlandarchive.scot.nhs.uk/isd/1631.html (accessed on
26 September 2011)
Jones R, Latinovic R, Charlton J, Gulliford MC (2007) Alarm
symptoms in early diagnosis of cancer in primary care: cohort
study using General Practice Research Database. BMJ 334(7602):
1040
Khan NF, Harrison SE, Rose PW (2010) Validity of diagnostic coding
within the General Practice Research Database: a systematic review. Br J
Gen Pract 60(572): e128–e136
Knottnerus JA (2002) The Evidence Base of Clinical Diagnosis. BMJ Books:
London
Larsen MB, Hansen RP, Olesen F, Vedsted P (2011) Patients’ confidence in
their GP before and after being diagnosed with cancer. Br J Gen Pract
61(586): e215–e222
Lawrenson R, Logie J, Marks C (2006) Risk of colorectal cancer
in general practice patients presenting with rectal bleeding,
change in bowel habit or anaemia. Eur J Cancer Care (Engl) 15(3):
267–271
National Institute for Health and Clinical Excellence (2005) National
Institute for Health and Clinical Excellence. Referral guidelines for
suspected cancer. http://www.nice.org.uk/nicemedia/live/10968/29814/
29814.pdf (accessed on 27 September 2011)
Northern Ireland Cancer Registry (2009) Cancer Incidence and Mortality.
http://www.qub.ac.uk/research-centres/nicr/FileStore/PDF/Incidence/
Filetoupload,210729,en.pdf (accessed on 26 September 2011)
Office for National Statistics (2000a) Key Health Statistics from General
Practice 1998. Series MB 6 No.2. ONS: London
Office for National Statistics (2000b) Table 1.5; Population age and sex.
Population Trends 102 102: 47–49
Office for National Statistics (2009) Cancer Statistics registrations:
Registrations of cancer diagnosed in 2007, England. Series MB1 no.38.
ONS: London
Olesen F, Hansen RP, Vedsted P (2009) Delay in diagnosis: the experience
in Denmark. Br J Cancer 101(Suppl 2): S5–S8
Stiller C, Kroll M, Eatock E (2007) Incidence of Childhood Cancer
1991–2000. In Childhood Cancer in Britain Incidence, Survival,
Mortality, Stiller C (ed) Vol. 1, Chapter 3, pp 23–106. Oxford University
Press: Oxford
Stolper E, van Bokhoven M, Houben P, Van Royen P, van de Wiel M, van
der Weijden T, Jan Dinant G (2009) The diagnostic role of gut feelings in
general practice. A focus group study of the concept and its
determinants. BMC Fam Pract 10: 17
Welsh Cancer Intelligence and Surveillance Unit (2009) Cancer Incidence
in Wales, 2004–2008. http://www.wales.nhs.uk/sites3/Documents/242/
incpub2010.pdf (accessed on 26 September 2011)
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the
license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
Features of childhood cancer in primary care
RM Dommett et al
987
British Journal of Cancer (2012) 106(5), 982 – 987& 2012 Cancer Research UK
E
p
id
e
m
io
lo
g
y
